Clinical Trial Update: Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea [Phase 3]

View source ↗

Summary

Phase 3 study of 0444 Gel for inflammatory rosacea has completed, with trial status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• 0444 Gel

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Inflammatory Rosacea | Phase 3 | Status: COMPLETED